- Home
- NMT vs RENB Comparison
NMT vs RENB Comparison
Compare NMT & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMT
- RENB
- Stock Information
- Founded
- NMT 1993
- RENB 2011
- Country
- NMT United States
- RENB United States
- Employees
- NMT N/A
- RENB N/A
- Industry
- NMT Finance/Investors Services
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- NMT Finance
- RENB Health Care
- Exchange
- NMT Nasdaq
- RENB Nasdaq
- Market Cap
- NMT 108.5M
- RENB 101.3M
- IPO Year
- NMT N/A
- RENB N/A
- Fundamental
- Price
- NMT $11.69
- RENB $0.50
- Analyst Decision
- NMT
- RENB
- Analyst Count
- NMT 0
- RENB 0
- Target Price
- NMT N/A
- RENB N/A
- AVG Volume (30 Days)
- NMT 19.1K
- RENB 336.3K
- Earning Date
- NMT 01-01-0001
- RENB 11-26-2024
- Dividend Yield
- NMT 3.21%
- RENB N/A
- EPS Growth
- NMT N/A
- RENB N/A
- EPS
- NMT N/A
- RENB N/A
- Revenue
- NMT N/A
- RENB N/A
- Revenue This Year
- NMT N/A
- RENB N/A
- Revenue Next Year
- NMT N/A
- RENB N/A
- P/E Ratio
- NMT N/A
- RENB N/A
- Revenue Growth
- NMT N/A
- RENB N/A
- 52 Week Low
- NMT $9.05
- RENB $0.40
- 52 Week High
- NMT $10.93
- RENB $5.25
- Technical
- Relative Strength Index (RSI)
- NMT 49.34
- RENB 43.00
- Support Level
- NMT $11.58
- RENB $0.56
- Resistance Level
- NMT $11.78
- RENB $0.65
- Average True Range (ATR)
- NMT 0.22
- RENB 0.08
- MACD
- NMT -0.01
- RENB -0.00
- Stochastic Oscillator
- NMT 38.10
- RENB 0.11
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified, closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.